Dongzhou Jeffrey Liu
President & Chief Scientific Officer - Global Research & Development Huadong Medicine Co.,Ltd
1. worked in the USA at 3 pharmaceutical companies of World Top 500 Companies including GSK, Wyeth/Pfizer; Forest Labs/Allegen；
2. 25+ years’ Global Pharmaceutical industry experiences include Clinical/Medical/Preclinical/Discover of medicinal products with leading/participating in 100+ projects with 10+ approved marketed drug products；
3. Published 100+ publications (original research articles and global conference presentations ) .
4. has 100+ PCT patent applications in which 20+ were granted
Seminars
Thursday 11th June 2026
Progresses in Developing Novel Targets ADCs of HDM’s XDC Technology & Its Clinical Focus on Solid Tumors With Enhanced Efficiency & Therapeutic Index
11:30 am
- Highlighting the strategy of HDM on the new generation of ADCs/XDCs, including novel targets, dual-payload, and sitespecific conjugation
- Discussing the preclinical and therapeutic implications of inhouse discovered novel payloads in widening the therapeutic window and conquering drug resistance
- Updating the preclinical and clinical data demonstrating enhanced potency, safety, and tumor-selective efficacy for HDM 2005, HDM 2012, and HDM2020
